Novonesis (novozymes) BNVZMF
13F holders, Q3 2025 (September 30)1holders
0new positions
0sold out
$61.25avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Novonesis (novozymes) B (NVZMF) in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holder was Boston Common Asset Management, LLC ($995K).
- Company
- Novonesis (novozymes) B
- Filed as
- NOVOZYMES A/S (Q3 2025)
- CUSIP
- K7317J133
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 337 shares sold, net −337 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Boston Common Asset Management, LLC | 0.03% | Reduce -2.0% | 16,253 | $995K |
"% of holder's portfolio" is NVZMF's weight in each manager's 13F, not the share of Novonesis (novozymes) B the manager owns.